KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Cash & Equivalents (2016 - 2025)

Cardinal Health's Cash & Equivalents history spans 17 years, with the latest figure at $2.8 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 27.11% year-over-year to $2.8 billion; the TTM value through Dec 2025 reached $2.8 billion, down 27.11%, while the annual FY2025 figure was $3.9 billion, 24.53% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $2.8 billion at Cardinal Health, down from $4.6 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $5.1 billion in Q2 2024 and bottomed at $2.4 billion in Q1 2022.
  • The 5-year median for Cash & Equivalents is $3.7 billion (2022), against an average of $3.7 billion.
  • The largest annual shift saw Cash & Equivalents crashed 32.67% in 2022 before it skyrocketed 69.35% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $3.2 billion in 2021, then rose by 15.6% to $3.7 billion in 2022, then grew by 25.64% to $4.6 billion in 2023, then fell by 17.01% to $3.8 billion in 2024, then decreased by 27.11% to $2.8 billion in 2025.
  • Per Business Quant, the three most recent readings for CAH's Cash & Equivalents are $2.8 billion (Q4 2025), $4.6 billion (Q3 2025), and $3.9 billion (Q2 2025).